MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

R Rupaimoole, FJ Slack - Nature reviews Drug discovery, 2017 - nature.com
In just over two decades since the discovery of the first microRNA (miRNA), the field of
miRNA biology has expanded considerably. Insights into the roles of miRNAs in …

FOXO transcription factor family in cancer and metastasis

Y Jiramongkol, EWF Lam - Cancer and Metastasis Reviews, 2020 - Springer
Forkhead box O (FOXO) transcription factors regulate diverse biological processes, affecting
development, metabolism, stem cell maintenance and longevity. They have also been …

A review on the role of cyclin dependent kinases in cancers

S Ghafouri-Fard, T Khoshbakht, BM Hussen… - Cancer Cell …, 2022 - Springer
The Cyclin-dependent kinase (CDK) class of serine/threonine kinases has crucial roles in
the regulation of cell cycle transition and is mainly involved in the pathogenesis of cancers …

[HTML][HTML] The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

S Yao, LYN Fan, EWF Lam - Seminars in cancer biology, 2018 - Elsevier
The FOXO3 and FOXM1 forkhead box transcription factors, functioning downstream of the
essential PI3K-Akt, Ras-ERK and JNK/p38MAPK signalling cascades, are crucial for cell …

miRNA profile in ovarian cancer

S Ghafouri-Fard, H Shoorei, M Taheri - Experimental and molecular …, 2020 - Elsevier
Ovarian cancer is a gynecological cancer with high mortality and a heterogeneous nature
which complicates its early detection and primary prevention. Numerous studies have …

Cancer hallmarks and microRNAs: the therapeutic connection

K Van Roosbroeck, GA Calin - Advances in cancer research, 2017 - Elsevier
Human cancers are characterized by a number of hallmarks, including sustained
proliferative signaling, evasion of growth suppressors, activated invasion and metastasis …

FOXM1: a multifunctional oncoprotein and emerging therapeutic target in ovarian cancer

C Liu, CJ Barger, AR Karpf - Cancers, 2021 - mdpi.com
Simple Summary Ovarian cancer is a lethal disease in women with a 10-year survival rate
of< 40% worldwide. A key molecular alteration in ovarian cancer is the aberrant …

The role of microRNAs in ovarian cancer

Y Kinose, K Sawada, K Nakamura… - BioMed research …, 2014 - Wiley Online Library
Ovarian cancer is the most lethal of malignant gynecological tumors. Its lethality may be due
to difficulties in detecting it at an early stage and lack of effective treatments for patients with …

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling

J Li, H Wu, W Li, L Yin, S Guo, X Xu, Y Ouyang, Z Zhao… - Oncogene, 2016 - nature.com
The aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of
cancer. However, the molecular mechanisms underlying the changes in miRNA expression …

MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome

L Jiang, J Huang, L Li, Y Chen, X Chen… - The Journal of …, 2015 - academic.oup.com
Context: MicroRNAs (miRNAs) are small, noncoding RNAs that negatively regulate gene
expression post-transcriptionally. Whether differently expressed miRNAs contribute to …